-
The neurosteroid dehydroepiandrosterone sulfate (DHEAS) reverses the dopaminergic deficiencies in mild hepatic encephalopathy: A possible therapeutic issue for the management of parkinsonism in cirrhotic patients
-
The NIC-PD-study –Baseline data of a randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson’s disease in Germany and the USA
-
The non-motor side of the honey-moon period of Parkinson’s disease
-
The non-motors symptoms in Parkinson’s disease patients with freezing of gait
-
The novel COMT-inhibitor ODM-104 and optimized carbidopa in combination with modified release levodopa reduce levodopa fluctuation and increase minimum concentrations in healthy subjects, when compared to the standard carbidopa/levodopa/entacapone combination
-
The nucleocytoplasmic transport of ataxin-3 as pathogenic mechanism in spinocerebellar ataxia type 3
-
The Parkinson progression marker initiative (PPMI) – Developing a comprehensive longitudinal biomarker dataset
-
The patient’s perspective: The effect of dopamine on Parkinson symptoms
-
The patterns of olfactory function in Parksinson’s disease patients with mild cognitive impairment
-
The phenotypic and genetic features of myoclonus-dystonia in six Saudi Arabian kindreds
- « Previous Page
- 1
- …
- 187
- 188
- 189
- 190
- 191
- …
- 207
- Next Page »